AlphAIAlphAI — Financial news for AI agents
SEC EDGAROCT 261 min read$LRCX

ARCHER TIMOTHY sold $7.1M of LRCX

ARCHER TIMOTHY (President and CEO) sold 31,400 shares of LAM RESEARCH CORP (LRCX) at $227.02 ($7.13M total) on 2026-10-23 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · ARCHER TIMOTHY
Published Oct 26, 2026, 5:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 26, 2026, 5:53 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$LRCX
Bearish
medium confidence
Mentioned
$LRCX
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LRCXBearishLow
01

Why it matters

The disclosed sale adds a modest negative data point but is unlikely to move the stock significantly.

02

Market read

A routine insider sale with limited market impact.

03

What to watch

The 10b5‑1 plan indicates the sale was pre‑scheduled, reducing informational value.

Relevance 5/10Novelty 4/10Timing: post‑filing today

Background

Form 4 filings disclose insider trades; investors monitor them for potential signals.

Company-level read

Ticker impact

$LRCXBearishMedium confidence
Context

SEC Form 4 shows CEO Archer Timothy sold 31,400 shares for $7.1M via a 10b5‑1 plan.

Expected impact

likely pressure as the market prices in the insider sell

Evidence & confidence

CEO offloading a sizable stake can be interpreted as lack of confidence, though the amount is modest relative to holdings.

Market effects

Sector

Minimal impact on semiconductor sector; only a single insider transaction.

Regional

No broader regional effect.

Global

Limited to investors tracking LRCX insider activity.

Counterpoint

What could challenge this read

The sale may be purely portfolio rebalancing under a pre‑arranged plan, not a bearish signal.

Key entities

  • person
    Archer Timothy

    President and CEO of Lam Research

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

LRCX insider trading history →

Related articles

OCT 30
$INTCMed

Semiconductor Stocks Fall as Intel Earnings Trigger Broad Tech Selloff

Semiconductor stocks fell after Intel's earnings miss and weak outlook, along with Amazon's earnings shortfall, sparking concerns about AI spending. Intel's stock dropped 25%, erasing $120B in market cap. Broadcom, AMD, Micron, Applied Materials, and Lam Research also declined. Qualcomm fell due to broader tech selloff. Alphabet and Amazon also reported revenue misses, while Meta plans $95B in stock offerings for AI investments.

morningstar.com6 min
OCT 28
$LRCXHigh

Chip Equipment Stocks Rally as SK Hynix Signals Memory Shortage Into 2030: Lam Research Jumps 5%, Applied Materials Climbs 4%, KLA Gains 3%

SK Hynix (SKHY) predicts a memory shortage until 2030, driving gains in chip equipment stocks. Lam Research (LRCX) rose 5%, Applied Materials (AMAT) 4%, and KLA (KLAC) 3%. SK Hynix's outlook suggests increased demand for fab equipment. Lam Research faces supply constraints, forecasting $8.6B in Q4 revenue. Applied Materials and KLA also reported growth. ASML (ASML) gained 1%.

247wallst.com3 min
OCT 28
$LRCXHighAI 8/10

Why is Lam Research stock rallying today?

Lam Research (LRCX) stock rose 3.4% after SK Hynix reported record Q3 2026 revenue and strong demand for memory chips. Analyst Lynx Equity reiterated a $400 price target, citing robust sector demand and potential share buybacks. The rally was driven by company-specific factors, not broader market trends.

investing.com1 min
OCT 27
$LRCXMed

Lam Research Stock Is 45% Below Its High. How Deep Have Past Drops Gone?

Lam Research (LRCX) shares have fallen 45.1% from their June 30 high, despite reporting record revenue. Historically, the stock has declined more than the S&P 500 during market shocks, with an average drop of 22.8%. The company's operating margin is at a 40-quarter high, and it holds $7.44 billion in cash. Management cited supply chain constraints for a cautious revenue forecast.

finance.yahoo.com3 min
OCT 27
$LRCXMedAI 8/10

Tech Sell-Off: This All-Star Artificial Intelligence Stock Is Down 50% but Up 127,300% Since Its IPO. Here's Why It's a Screaming Buy Heading Into the Midterms.

Lam Research (LRCX) stock is down 50% from its June high but up 127,300% since its 1984 IPO. The semiconductor equipment maker reported record Q3 revenue of $8.22B and EPS of $2.20, beating estimates. Despite strong results, the stock fell due to 'light' guidance of $8.6B revenue and $2.33 EPS for Q4, attributed to supply constraints. Management forecasts industrywide wafer front-end equipment spending to exceed $200B by 2027, with Lam expected to grow faster than the industry.

finance.yahoo.com3 min
OCT 26
$LRCXMed

Lam Research Stocks Gain 4.3% Despite Citi's Target Cut

Lam Research (LRCX) shares rose 4.3% to $239.93 on October 26, despite Citi cutting its price target while maintaining a Buy rating. The company projected December-quarter revenue of $8.6 billion, with a 40.2% adjusted operating margin in September. Investors will watch for earnings growth to meet expectations.

finance.yahoo.com2 min